Active Stocks

Tue May 13 2025 15:29:57

Tata Steel share price
149.40 -1.42%

Tata Motors share price
708.00 -1.74%

Itc share price
427.60 -1.81%

Reliance Industries share price
1,416.70 -1.38%

Power Grid Corporation Of India share price
299.10 -3.22%

Business News > Mint Authors > Ketaki Gokhale

Ketaki Gokhale

Mint Author

ARTICLES BY KETAKI GOKHALE

The transaction will give Pfizer rights to three medicines already on the market, including Zavicefta, which is used to treat severe bacterial infections resistant to other drugs. Photo: Bloomberg

Pfizer to buy antibiotics business from AstraZeneca for $725 mn

2 min read . 24 Aug 2016

EMA’s recommendation for suspension will be sent to the European Commission for a legally binding decision valid throughout the European Union. Photo: Pradeep Gaur/Mint

Flawed Indian studies spur EU regulator to back drug suspensions

1 min read . 22 Jul 2016

Losing revenue from its top-selling drug would be the latest blow to AstraZeneca, which has already seen sales tumble as patents expire on some of its leading medicines. Photo: Bloomberg

Indian firms get approval for generics of AstraZeneca’s Crestor

1 min read . 20 Jul 2016

Sofosbuvir was cheap by any standard when it hit the market in Punjab at $10 (around Rs670) in March. Then the cost kept dropping, to as low as $4.29, and doctors predict it will continue to fall. Photo: Bloomberg

The price keeps falling for a superstar Gilead hepatitis C drug in India

5 min read . 29 Dec 2015

Second-round bids are due this week and the sale could fetch from $500 million to $800 million. Photo: Reuters

Glenmark, Sun Pharma, Cipla said to weigh bid for Teva portfolio

1 min read . 02 Dec 2015

Dr. Reddy’s dropped 8.5% on Thursday, making the stock the worst performer on the Bloomberg World Pharmaceuticals Index over the past five days. Photo: Priyanka Parashar/Mint

US FDA warning poses threat to Dr Reddy’s revenue outlook

2 min read . 28 Nov 2015

Photo: Bloomberg

Indian drug makers engineer hepatitis C cocktails impossible in West

5 min read . 10 Oct 2015

Selling a 10% stake at that valuation would be the largest private-equity investment in India, according to data compiled by Bloomberg. Photo: Mint

Serum Institute in talks for stake sale at $12 billion valuation

2 min read . 18 Sep 2015

Dr. Reddy’s has lost market share in generic Lipitor this year while Mylan NV and Apotex Inc. sold a bigger share of the cholesterol lowering drug.

Indian drug makers feel the pressure as US pharmacies consolidate

4 min read . 28 Aug 2015

A cottage industry of drug distributors is emerging to offer patients in the US and other developed countries cheap copies of Sovaldi from countries where it is sold for 1% of the US price. Photo: Pradeep Gaur/Mint

US hepatitis C patients travel to India for cheaper Sovaldi versions

10 min read . 02 Jun 2015

Lupin Ltd is India’s second-largest drug maker by market value. Photo: Bloomberg

Lupin, Cipla said to bid for UCB’s $1 billion US generics business

1 min read . 02 Jun 2015

Widening its pipeline into injectable drugs would help Dr. Reddy’s gain a foothold in an area where shortages are frequent and competition is less intense because of the complexity of the products. Photo: Mint

Dr. Reddy’s expanding injectable drug offerings, seeking deals

3 min read . 26 Mar 2015

India, whose public spending on health as a percentage of GDP is among the lowest in the world, is racing to procure more antiviral drugs for its emergency stocks. Photo: PTI (PTI)

Swine flu surge fuels concern about a resistant virus strain

3 min read . 26 Feb 2015

The world’s biggest drugmakers—including Merck, GlaxoSmithKline, Sanofi and Pfizer Inc.—dominate the market because of the heavy investments needed to develop vaccines and the high failure rate of potential candidates. Photo: Bloomberg

Top-selling vaccine made cheap shows challenge to Merck

4 min read . 27 Jan 2015

Indian govt also caps many drug prices to ensure that the country’s poorest can afford them. Photo: Blooomberg

Gilead’s India patent snag may spur more low-cost Sovaldi copies

2 min read . 15 Jan 2015

Sun’s plant at Vadodara was banned four months after its inspection. A senior quality control officer told FDA investigators that lab employees there frequently pretested samples before recording a final result, according to the agency’s warning letter to Sun. Photo: Bloomberg

Drug batch tainted? Just hit delete and ship it to US

10 min read . 04 Dec 2014

While not as visible as the dead frogs and flies inspectors have found in other Indian labs, the pattern of data integrity breaches worries doctors in the US and elsewhere. Photo: Mint

Indian labs deleted test results for US drugs, FDA documents show

10 min read . 03 Dec 2014

The US food and drug administration (FDA) blamed the ‘compliance status’ of Ranbaxy’s factories for its decision, the company said on Thursday. Photo: Mint

Ranbaxy shares drop the most in two months after FDA hurdle

1 min read . 07 Nov 2014

The worst-ever outbreak of the epidemic has killed more than 4,400, with its core in Guinea, Sierra Leone and Liberia. Photo: AFP

What’s Ebola? Mumbai takes crash course as virus spreads

6 min read . 24 Oct 2014

Wockhardt’s revenue, which took a hit after the US action, is projected to rebound to almost $1 billion in 2017 as the company rolls out new products at home. Photo: Bloomberg

Wockhardt comeback sets up Indian drug maker as takeover target

5 min read . 04 Sep 2014